Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea flag South Korea · Delayed Price · Currency is KRW
120,800
+1,600 (1.34%)
At close: Mar 25, 2025, 3:30 PM KST

Daewoong Pharmaceutical Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Operating Revenue
1,422,6831,375,3291,280,0921,152,9761,055,424
Upgrade
Other Revenue
-0-0-0-0-
Upgrade
Revenue
1,422,6831,375,3291,280,0921,152,9761,055,424
Upgrade
Revenue Growth (YoY)
3.44%7.44%11.03%9.24%-5.21%
Upgrade
Cost of Revenue
689,472688,221641,997609,227609,435
Upgrade
Gross Profit
733,211687,108638,095543,749445,989
Upgrade
Selling, General & Admin
396,260376,109366,091315,434299,358
Upgrade
Research & Development
171,290171,573163,602127,269115,218
Upgrade
Other Operating Expenses
4,4764,3824,2973,5543,531
Upgrade
Operating Expenses
587,973565,990542,297455,020429,009
Upgrade
Operating Income
145,238121,11895,79788,72916,980
Upgrade
Interest Expense
-6,986-13,603-8,406-10,248-10,610
Upgrade
Interest & Investment Income
5,0943,0994,1352,5693,423
Upgrade
Earnings From Equity Investments
-23,15329,977-374.54257.52-355.37
Upgrade
Currency Exchange Gain (Loss)
6,261-1,705-40.313,246-6,548
Upgrade
Other Non Operating Income (Expenses)
-28,994-13,423-43,639-69,9628,622
Upgrade
EBT Excluding Unusual Items
97,459125,46247,47314,59111,511
Upgrade
Gain (Loss) on Sale of Investments
-24,951130.67-4,1718,3082,622
Upgrade
Gain (Loss) on Sale of Assets
-465.97-1,221246.4-1,0297,530
Upgrade
Asset Writedown
-15,492-2,372-5,219-2,109-8,103
Upgrade
Pretax Income
56,550121,99938,33019,76113,559
Upgrade
Income Tax Expense
33,2041,996-833.51-10,323-10,589
Upgrade
Earnings From Continuing Operations
23,347120,00339,16330,08424,148
Upgrade
Minority Interest in Earnings
1,3881,7363,076-5,578-11,395
Upgrade
Net Income
24,735121,73942,24024,50612,753
Upgrade
Net Income to Common
24,735121,73942,24024,50612,753
Upgrade
Net Income Growth
-79.68%188.21%72.37%92.15%-42.05%
Upgrade
Shares Outstanding (Basic)
1211111111
Upgrade
Shares Outstanding (Diluted)
1211111111
Upgrade
Shares Change (YoY)
0.71%3.21%0.59%3.21%3.31%
Upgrade
EPS (Basic)
2149.6510655.613815.952226.871196.10
Upgrade
EPS (Diluted)
2149.6510655.613815.952226.871196.10
Upgrade
EPS Growth
-79.83%179.24%71.36%86.18%-43.90%
Upgrade
Free Cash Flow
-103,65326,67152,98810,90674,495
Upgrade
Free Cash Flow Per Share
-9008.372334.474786.97991.086986.64
Upgrade
Gross Margin
51.54%49.96%49.85%47.16%42.26%
Upgrade
Operating Margin
10.21%8.81%7.48%7.70%1.61%
Upgrade
Profit Margin
1.74%8.85%3.30%2.13%1.21%
Upgrade
Free Cash Flow Margin
-7.29%1.94%4.14%0.95%7.06%
Upgrade
EBITDA
194,217164,915135,492129,61357,861
Upgrade
EBITDA Margin
13.65%11.99%10.59%11.24%5.48%
Upgrade
D&A For EBITDA
48,97843,79739,69540,88340,882
Upgrade
EBIT
145,238121,11895,79788,72916,980
Upgrade
EBIT Margin
10.21%8.81%7.48%7.70%1.61%
Upgrade
Effective Tax Rate
58.72%1.64%---
Upgrade
Advertising Expenses
74,10179,24580,58759,08151,192
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.